Cystinuria News

Natural Antioxidant Boosts Therapeutic Potential Original Story Here University of Barcelona What began as research aimed at expanding the limited treatment options for cystinuria, a rare genetic disorder affecting one in every [...]

How variant discovery redefines genetic prevalence: the case of cystine stone disease Original Story Here Abstract Cystine stones are caused by pathogenic variants in SLC3A1 or SLC7A9. Our prior study revealed a large gap between [...]

Cystinuria Treatment Market to Reach US$ 216.50 Million by 2030 at 4.80% CAGR; North America Leads with 40% Share - Key Players: Travere Therapeutics, Teva Pharmaceutical, Advicenne Original Story Here Cystinuria Treatment [...]

Tiopronin Safety in Cystinuria: First Real-World Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System (FAERS): An EAU YAU and Endourology Sections Review - Beyond the Abstract Cystinuria is a lifelong hereditary [...]

Partial correction of cystinuria type A in mice via kidney-targeted transposon delivery We used kidney-targeted, non-viral, transposon-mediated gene delivery to express the mouse Slc3a1 transgene in one kidney of cystinuria type A (Slc3a1−/−) mice. [...]

Non-viral gene therapy to treat cystinuria Aug. 4, 2025 Original Story  (Unfortunately the story is buried behind a paywall so we may need to wait for the study to be published before [...]

Cystinuria Pipeline Insight 2025: Redefining Treatment through Precision Therapies and Rare Disease Innovation | DelveInsight Original Story 07-21-2025 04:20 PM CET | Health & Medicine Press release from: DelveInsight DelveInsight's "Cystinuria - Pipeline Insight, [...]

Cystinuria Pipeline Insight 2025: Redefining Treatment through Precision Therapies and Rare Disease Innovation | DelveInsight Original Story Professor Richard Coward from the University of Bristol has received a Kidney Research UK research project grant of £230,000 to [...]

“Go big or go small”: Current and emerging tools in kidney stone management Original Story Key Takeaways Recent advancements in kidney stone management include novel access sheaths and miniaturized scopes, enhancing treatment [...]

Sexual Dimorphism in Cystinuria- The Mitochondria Link Original Story Unravelling the role of mitochondrial Slc3a1 in regulating mitochondrial functions and sexual dimorphism in cystinuria CHINA, March 28, 2025 /EINPresswire.com/ -- Cystinuria is the most [...]

New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria Original Story BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment [...]

Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria Original Story PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company [...]